Annual Cash & Cash Equivalents
$5.16 M
-$4.59 M-47.08%
December 31, 2023
Summary
- As of February 12, 2025, AEON annual cash & cash equivalents is $5.16 million, with the most recent change of -$4.59 million (-47.08%) on December 31, 2023.
- During the last 3 years, AEON annual cash & cash equivalents has fallen by -$15.01 million (-74.42%).
- AEON annual cash & cash equivalents is now -74.42% below its all-time high of $20.17 million, reached on December 1, 2020.
Performance
AEON Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$537.00 K
-$2.90 M-84.40%
September 30, 2024
Summary
- As of February 12, 2025, AEON quarterly cash and cash equivalents is $537.00 thousand, with the most recent change of -$2.90 million (-84.40%) on September 30, 2024.
- Over the past year, AEON quarterly cash and cash equivalents has dropped by -$1.02 million (-65.53%).
- AEON quarterly cash and cash equivalents is now -97.34% below its all-time high of $20.17 million, reached on December 31, 2020.
Performance
AEON Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AEON Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.1% | -65.5% |
| 3 y3 years | -74.4% | -94.5% |
| 5 y5 years | -18.4% | -94.5% |
AEON Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -47.1% | +0.6% | -96.7% | at low |
| 5 y | 5-year | -74.4% | +0.6% | -97.3% | at low |
| alltime | all time | -74.4% | +0.6% | -97.3% | at low |
AEON Biopharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $537.00 K(-84.4%) |
| Jun 2024 | - | $3.44 M(+120.9%) |
| Mar 2024 | - | $1.56 M(-90.4%) |
| Dec 2023 | $5.16 M(-47.1%) | - |
| Sep 2023 | - | $16.18 M(+66.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $9.75 M(+90.1%) | $9.75 M(+90.1%) |
| Dec 2021 | $5.13 M(-74.6%) | $5.13 M(-51.6%) |
| Jun 2021 | - | $10.61 M(-47.4%) |
| Dec 2020 | - | $20.17 M |
| Dec 2020 | $20.17 M(+218.9%) | - |
| Dec 2019 | $6.32 M | - |
FAQ
- What is AEON Biopharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AEON Biopharma?
- What is AEON Biopharma annual cash & cash equivalents year-on-year change?
- What is AEON Biopharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for AEON Biopharma?
- What is AEON Biopharma quarterly cash and cash equivalents year-on-year change?
What is AEON Biopharma annual cash & cash equivalents?
The current annual cash & cash equivalents of AEON is $5.16 M
What is the all time high annual cash & cash equivalents for AEON Biopharma?
AEON Biopharma all-time high annual cash & cash equivalents is $20.17 M
What is AEON Biopharma annual cash & cash equivalents year-on-year change?
Over the past year, AEON annual cash & cash equivalents has changed by -$4.59 M (-47.08%)
What is AEON Biopharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AEON is $537.00 K
What is the all time high quarterly cash and cash equivalents for AEON Biopharma?
AEON Biopharma all-time high quarterly cash and cash equivalents is $20.17 M
What is AEON Biopharma quarterly cash and cash equivalents year-on-year change?
Over the past year, AEON quarterly cash and cash equivalents has changed by -$1.02 M (-65.53%)